Skip to main content
FDA Okays Subcutaneous Ocrelizumab for MS
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA Okays Subcutaneous Ocrelizumab for MS
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Sclerosis
1
1
Blood
0
0.63
Intravenous
0
0.54
Europe
0
0.32
Food and Drug Administration (FDA)
0
0.32
Multiple Sclerosis Relapse
0
0.99
Primary Progressive Multiple Sclerosis
0
0.98
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Internal Medicine
0
0.9
Pharmacist
0
0.8
Edit Tags